IMIDES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE, α, ФHO Russian patent published in 2001 - IPC

Abstract RU 2174512 C2

FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention describes novel compounds of the general formula (I) ЯФкB where one of and R1 = R2 is X and other means lower alkoxy-group; R3 is monocycloalkyl, bicycloalkyl, benzocyclo-alkyl with a number of carbon atoms up to 10; X is -O-; R3 is CO, R6; Y is -COZ, lower alkyl; Z is CH2-, -OH, NH2 or -R9 where -OR9 is lower alkyl and n = 0, 1, 2 and 3. New amides are inhibitors of R9 and phosphodiesterase and can be used for control of cachexia, endotoxic shock, replication of retro-viruses, asthma and inflammatory states. Typical example of these compounds is 3-phthalimido-3-(3-cyclopentylhydroxy-4- -methoxyphenyl)-propionamide. Invention describes also pharmaceutical composition based on these compounds and methods of inhibition of activity phosphodiesterae, ФHOα and ФHOα. EFFECT: new compounds indicated above, improved method of inhibition. 8 cl, 1 tbl, 22 ex

Similar patents RU2174512C2

Title Year Author Number
IMIDE/AMIDE ETHERS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF FNOK LEVEL IN MAMMALIAN 1995
  • Dzhordzh Mjuller
  • Mehri Shir
  • Dehvid I. Stirling
RU2164514C2
IMMUNOTHERAPEUTIC IMIDES/AMIDES AS INHIBITORS OF PHOSPHODI-ESTERASE-IV (PDE-IV) AND TUMOR NECROSIS FACTOR (TNF) 1997
  • Maller Dzhordzh U.
  • Shajr Mehri
  • Sterling Dejvid I.
RU2177471C2
SUBSTITUTED HYDROXAMIC ACIDS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF AND METHOD OF TNF (TUMOR NECROSIS FACTOR) α DECREASE 1998
  • Maller Dzhordzh V.
  • Man Khon-Vo
RU2199530C2
SUCCINIMIDE AND MALEIMIDE INHIBITORS OF CYTOKINS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF TUMOR NECROSIS α-FACTOR 1996
  • Dzhordzh V. Mjuller
  • Mehri Shajr
RU2176242C2
SUBSTITUTED AMIDES, METHOD OF DECREASE OF TUMOR NECROSIS FACTOR (TNF) LEVEL AND INHIBITION OF PHOSPHODIESTERASE ACTIVITY AND PHARMACEUTICAL COMPOSITION 1996
  • Mjuller Dzhordzh V.
  • Shajr Mehri
RU2196134C2
ARYLAMIDES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF TNF-ACTIVATED RETROVIRUS REPLICATION 1995
  • Dzhordzh Mjuller
  • Mehri Shir
  • Dehvid I. Stirling
RU2162839C2
NOVEL IMMUNOTHERAPEUTIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND METHOD OF DECREASE OF LEVELS OF PHDE, TNF ALPHA AND NFKB 1997
  • Maller Dzhordzh U.
  • Shajr Mehri
RU2188819C2
SUBSTITUTED AMIDES, METHOD OF DECREASE OF TNF LEVEL, METHOD OF INHIBITION OF TNF-ACTIVATED REPLICATION OF RETROVIRUSES AND PHARMACEUTICAL COMPOSITION 1995
  • Dzhordzh Mjuller
  • Meri Shir
  • Dehvid I. Stirling
RU2162078C2
IMIDES AS TNF-ALPHA INHIBITORS 1994
  • Mjuller Dzhordzh V.
RU2174516C2
OXIME CARBAMATES AND OXIME CARBONATES 1991
  • Lombardo Louis Dzhon[Us]
RU2051145C1

RU 2 174 512 C2

Authors

Maller Dzhordzh V.

Shajr Mehri

Dates

2001-10-10Published

1996-12-24Filed